Mirapexin prolonged-release tablets

Company:
Boehringer Ingelheim Limited
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may be renewed (B)
Active Ingredient(s):
Pramipexole Dihydrochloride Monohydrate
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/97/051/25-27

3.15 milligram(s)

N04BC05

Prolonged-release tablet

EU/1/97/051/028-30

1.57 milligram(s)

N04BC05

Prolonged-release tablet

EU/1/97/051/031-33

2.62 milligram(s)

N04BC05

Prolonged-release tablet

EU/1/97/051/13-15

0.26 milligram(s)

N04BC05

Prolonged-release tablet

EU/1/97/051/16-18

0.52 milligram(s)

N04BC05

Prolonged-release tablet

EU/1/97/051/19-21

1.05 milligram(s)

N04BC05

Prolonged-release tablet

EU/1/97/051/22-24

2.1 milligram(s)

N04BC05

Prolonged-release tablet